Inflammation: therapeutic targets for diabetic neuropathy
For best results, apply both morning and night
262, www.ijdvl.com/article.asp?issn=0378-6323;year=2016;volume=82;issue=3;spage=262;epage=272;aulast=Sonthalia, ---
It is worth noting that one of the recently approved ALS therapies (sodium phenylbutyrate + TUDCA, as mentioned earlier) highlights the intersection of microbiome-related metabolism and neurodegeneration [224]
Studies have shown that neuroinflammation can lead to increased excitability of locus coeruleus neurons, which may contribute to increased anxiety and depressive symptoms [346]
Sufferers of pernicious anaemia, which causes memory loss, extreme fatigue and irrational behaviour, receive an NHS vitamin B12 jab every three months